Log in to save to my catalogue

Antiviral Effects of Novel 2-Benzoxyl-Phenylpyridine Derivatives

Antiviral Effects of Novel 2-Benzoxyl-Phenylpyridine Derivatives

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_841b1bd938cb4588b361712153d86ce8

Antiviral Effects of Novel 2-Benzoxyl-Phenylpyridine Derivatives

About this item

Full title

Antiviral Effects of Novel 2-Benzoxyl-Phenylpyridine Derivatives

Publisher

Switzerland: MDPI

Journal title

Molecules (Basel, Switzerland), 2020-03, Vol.25 (6), p.1409

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI

More information

Scope and Contents

Contents

Coxsackievirus B3 (CVB3) is the most common cause of acute and chronic viral myocarditis, primarily in children, while human adenovirus infections represent a significant cause of morbidity and mortality worldwide, in people of all ages. A series of novel 2-benzoxyl-phenylpyridine derivatives were evaluated for their potential antiviral activities...

Alternative Titles

Full title

Antiviral Effects of Novel 2-Benzoxyl-Phenylpyridine Derivatives

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_841b1bd938cb4588b361712153d86ce8

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_841b1bd938cb4588b361712153d86ce8

Other Identifiers

ISSN

1420-3049

E-ISSN

1420-3049

DOI

10.3390/molecules25061409

How to access this item